Here are three points:
1. Twelve Wall Street firms have rated the company’s stock as a “strong buy.”
2. Boston Scientific has a 52-week high of $23.35 and a 52-week low of $14.18.
3. The company’s market cap is $1.3 billion.
More articles on GI/endoscopy:
4 things to know about Healthmark’s Endoscope Cleaning Brush
5 most read GI/endoscopy stories: June 13 — June 17
Ohio Gastroenterology & Liver Institute incorporates HyGIeaCare Prep System: 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.